Aminocyclopentane esters and pharmaceutical formulations
US4530925A · kind A · utility
3Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1984 |
| Grant date | Jul 23, 1985 |
| Priority date | — |
| Expiry date | Mar 14, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds are described of the formulae (1a) and (1b) ##STR1## in which: --COR.sup.1 is an ester group, PA1 n is 1 or 2, PA1 W is C.sub.1-7 alkylene, PA1 X is cis or trans --CH.dbd.CH or --CH.sub.2 CH.sub.2 --, PA1 Y is a saturated heterocyclic amino group, PA1 R.sup.2 is substituted or unsubstituted phenylalkyl, thienylalkyl or naphthylalkyl or cinnamyl, and PA1 R.sup.3 is --H or C.sub.1-5 alkanoyl, including their salts. These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic or antiasthmatic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.